Green inner page banner

Scleroderma and Interstitial Lung Disease webinar

June 5 2023 1:00 pm

Event Details

Patient Education, Webinar

  • June 5 2023
  • 1:00 pm
Register now

As part of our Pulmonary Fibrosis webinar series, we are pleased to present the Scleroderma and Interstitial Lung Disease webinar.

Dr Mathew Parker, Rheumatologist, and Dr Alan Teoh, Respiratory and Sleep Physician will provide an overview of scleroderma and an insight into how to navigate the diagnosis and management of your condition, to get the most out of your treatment and care.  

Both pre-submitted and live questions from participants joining the webinar will be answered by the presenters.    

Date: Monday 05th June. 
Time: 1:00pm (QLD, NSW, VIC, TAS, ACT), 12:30pm (NT, SA), 11:00am (WA) 


Speaker bios 

Dr Matthew Parker, Rheumatologist 

Dr Matthew Parker is a Staff Specialist in Rheumatology at the Royal Prince Alfred Hospital in Sydney. He has a special clinical and research interest in autoimmune and related muscle diseases and in Connective Tissue disease-associated Interstitial Lung Disease (CTD-ILD). 

Dr Alan Teoh, Respiratory and Sleep Physician 

Dr Alan Teoh is a respiratory and sleep physician at Royal Prince Alfred Hospital where he is involved in the ILD clinic. He also holds a postgraduate Fellow position at Westmead Hospital and co-runs the ILD service there. Alan is undertaking a PhD at the University of Sydney and Royal Prince Alfred Hospital. His research is focused on IPF but includes other forms of ILD. 

Dr Teoh completed his Bachelor of Medicine and Surgery at the University of Tasmania. He completed his BPT training at RPA hospital and continued his respiratory advanced training at Westmead Hospital. He has a special interest in interstitial lung diseases, particularly idiopathic pulmonary fibrosis. 

Rossana Reyes, Patient

Rosanna has been living with diffuse Scleroderma since 2019. Rossana works in Revenue within health and enjoys spending time outdoors with her family.

Proudly sponsored by
Boehringer Ingelheim

In collaboration with   
The Centre of Research Excellence in Pulmonary Fibrosis